Treatment.Com International Inc. (TRUE.CN)
CAD 0.44
(3.57%)
CAD 0.44
(3.57%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.47 Million CAD | -32.92% |
| 2022 | 2.2 Million CAD | 164.5% |
| 2021 | 832.61 Thousand CAD | 44.44% |
| 2020 | 576.46 Thousand CAD | 248.77% |
| 2019 | 165.28 Thousand CAD | 208.89% |
| 2018 | 53.5 Thousand CAD | 12.0% |
| 2017 | 47.77 Thousand CAD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 660.07 Thousand CAD | -56.39% |
| 2024 Q1 | 1.51 Million CAD | 2.45% |
| 2023 Q4 | 1.47 Million CAD | -13.35% |
| 2023 Q3 | 1.7 Million CAD | -37.06% |
| 2023 Q2 | 2.7 Million CAD | 7.69% |
| 2023 Q1 | 2.51 Million CAD | 14.23% |
| 2023 FY | 1.47 Million CAD | -32.92% |
| 2022 Q4 | 2.2 Million CAD | 45.66% |
| 2022 Q2 | 1.25 Million CAD | 21.01% |
| 2022 Q1 | 1.03 Million CAD | 24.35% |
| 2022 FY | 2.2 Million CAD | 164.5% |
| 2022 Q3 | 1.51 Million CAD | 20.67% |
| 2021 Q1 | 317.39 Thousand CAD | -44.94% |
| 2021 FY | 832.61 Thousand CAD | 44.44% |
| 2021 Q4 | 832.61 Thousand CAD | 16.73% |
| 2021 Q3 | 713.27 Thousand CAD | 2.12% |
| 2021 Q2 | 698.49 Thousand CAD | 120.07% |
| 2020 Q4 | 576.46 Thousand CAD | 41.02% |
| 2020 Q1 | - CAD | -100.0% |
| 2020 Q3 | 408.77 Thousand CAD | 0.0% |
| 2020 FY | 576.46 Thousand CAD | 248.77% |
| 2019 FY | 165.28 Thousand CAD | 208.89% |
| 2019 Q4 | 165.28 Thousand CAD | 0.0% |
| 2018 FY | 53.5 Thousand CAD | 12.0% |
| 2017 FY | 47.77 Thousand CAD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AI/ML Innovations Inc. | 1.53 Million CAD | 4.046% |
| Diagnamed Holdings Corp. | 426.38 Thousand CAD | -246.489% |
| Pangenomic Health Inc. | 2.21 Million CAD | 33.335% |
| nDatalyze Corp. | 38.26 Thousand CAD | -3761.367% |
| Unidoc Health Corp. | 2.38 Million CAD | 37.937% |